Volume 106, Issue 9, September 2014

NEWS

New Hope for Young Breast Cancer Patients

Judy Peres

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju308, https://doi.org/10.1093/jnci/dju308

• Extract
• View article

Alleviating the Crisis in Cancer Care

Cathryn M. Delude

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju309, https://doi.org/10.1093/jnci/dju309

• Extract
• View article

Marshaling the Immune System to Eliminate Minimal Residual Disease in B-ALL

Karyn Hede

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju307, https://doi.org/10.1093/jnci/dju307

• Extract
• View article

Open Payments Program (aka the Sunshine Act) Makes Public Debut

Charlie Schmidt

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju312, https://doi.org/10.1093/jnci/dju312

• Extract
• View article

PDQ (Physician Data Query)

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju310, https://doi.org/10.1093/jnci/dju310

• Extract
• View article

STAT BITE

Stat Bite Breast Cancer Incidence by Age in the United States per 100 000 (2006–2010)

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju311, https://doi.org/10.1093/jnci/dju311

• Extract
• View article

COMMENTARIES

Adult Cancer Clinical Trials That Fail to Complete: An Epidemic?

Kristian D. Stensland and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju229, https://doi.org/10.1093/jnci/dju229

• Abstract
• View article
• Supplementary data

Development of the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Ethan Basch and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju244, https://doi.org/10.1093/jnci/dju244

• Abstract
• View article

Cancer Treatment–Related Cardiotoxicity: Current State of Knowledge and Future Research Priorities

Nonniekaye Shelburne and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju232, https://doi.org/10.1093/jnci/dju232

• Abstract
• View article
• Supplementary data

REVIEWS

Comparative Effectiveness of Neoadjuvant Therapy for HER2–Positive Breast Cancer: A Network Meta-Analysis

Aiko Nagayama and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju203, https://doi.org/10.1093/jnci/dju203

• Abstract
• View article
• Supplementary data

Outcome Reporting in Neoadjuvant Surgical Trials: A Systematic Review of the Literature and Proposals for New Standards

N. S. Blencowe and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju217, https://doi.org/10.1093/jnci/dju217

• Abstract
• View article

Cancer Chemoprevention With Nuts

Marco Falasca and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju238, https://doi.org/10.1093/jnci/dju238

• Abstract
• View article

Circulating Fatty Acids and Prostate Cancer Risk: Individual Participant Meta-Analysis of Prospective Studies

Francesca L. Crowe and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju240, https://doi.org/10.1093/jnci/dju240

• Abstract
• View article
• Supplementary data

EDITORIAL

Making Sense of Dual HER2-Targeting in Early Breast Cancer?

Lisa A. Carey and William Barry

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju259, https://doi.org/10.1093/jnci/dju259

• Extract
• View article

ARTICLES

The Effects of Soy Supplementation on Gene Expression in Breast Cancer: A Randomized Placebo-Controlled Study

Moshe Shike and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju189, https://doi.org/10.1093/jnci/dju189

• Abstract
• View article
• Supplementary data

mTOR Co-Targeting in Cetuximab Resistance in Head and Neck Cancers Harboring PIK3CA and RAS Mutations

Zhiyong Wang and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju215, https://doi.org/10.1093/jnci/dju215

• Abstract
• View article
• Supplementary data

Tumor LINE-1 Methylation Level and Microsatellite Instability in Relation to Colorectal Cancer Prognosis

Kentaro Inamura and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju195, https://doi.org/10.1093/jnci/dju195

• Abstract
• View article
• Supplementary data

Clinical Significance of CTNNB1 Mutation and Wnt Pathway Activation in Endometrioid Endometrial Carcinoma

Yuexin Liu and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju245, https://doi.org/10.1093/jnci/dju245

• Abstract
• View article
• Supplementary data

Perineal Powder Use and Risk of Ovarian Cancer

Serena C. Houghton and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju208, https://doi.org/10.1093/jnci/dju208

• Abstract
• View article

MicroRNA Detection in Cervical Exfoliated Cells as a Triage for Human Papillomavirus–Positive Women

Qifang Tian and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju241, https://doi.org/10.1093/jnci/dju241

• Abstract
• View article
• Supplementary data

TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma

Klaus G. Griewank and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju246, https://doi.org/10.1093/jnci/dju246

• Abstract
• View article
• Supplementary data

Risk of Premature Menopause After Treatment for Hodgkin’s Lymphoma

Anthony J. Swerdlow and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju207, https://doi.org/10.1093/jnci/dju207

• Abstract
• View article
• Supplementary data

EDITORIAL

Avoiding the Bad and Enhancing the Good of Soy Supplements in Breast Cancer

V. Craig Jordan

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju233, https://doi.org/10.1093/jnci/dju233

• Extract
• View article

EDITORIAL

Talc Use and Ovarian Cancer: Epidemiology Between a Rock and a Hard Place

Nicolas Wentzensen and Sholom Wacholder

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju260, https://doi.org/10.1093/jnci/dju260

• Extract
• View article

EDITORIAL

Risk of Premature Menopause After Treatment for Hodgkin’s Lymphoma

Ronald D. Barr

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju231, https://doi.org/10.1093/jnci/dju231

• Extract
• View article

BRIEF COMMUNICATIONS

Selective Antitumor Activity of Ibrutinib in EGFR-Mutant Non–Small Cell Lung Cancer Cells

Wen Gao and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju204, https://doi.org/10.1093/jnci/dju204

• Abstract
• View article
• Supplementary data

Randomized Trial of [¹³¹I] Metuximab in Treatment of Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation

Huijie Bian and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju239, https://doi.org/10.1093/jnci/dju239

• Abstract
• View article
• Supplementary data

Response

Sounok Sen and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju198, https://doi.org/10.1093/jnci/dju198

• Extract
• View article

EDITORIAL

Deploying Ibrutinib to Lung Cancer: Another Step in the Quest Towards Drug Repurposing

Eric B. Haura and Uwe Rix

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju250, https://doi.org/10.1093/jnci/dju250

• Extract
• View article

CORRESPONDENCE

RE: Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer

Nicolas Bakinde and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju253, https://doi.org/10.1093/jnci/dju253

• Extract
• View article

Response

Ning Qing Liu and others

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju254, https://doi.org/10.1093/jnci/dju254

• Extract
• View article

ERRATUM

Erratum

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju273, https://doi.org/10.1093/jnci/dju273

• Extract
• View article

Erratum

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju280, https://doi.org/10.1093/jnci/dju280

• Extract
• View article

MEMO TO THE MEDIA

Soy Supplementation Adversely Effects Expression of Breast Cancer-Related Genes

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, dju313, https://doi.org/10.1093/jnci/dju313

• Extract
• View article

COVER

Cover

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, djt426, https://doi.org/10.1093/jnci/djt426

• View article

STANDING MATERIAL

Editorial_Board

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, djt427, https://doi.org/10.1093/jnci/djt427

• View article

Table_of_Contents

JNCI: Journal of the National Cancer Institute, Volume 106, Issue 9, September 2014, djt429, https://doi.org/10.1093/jnci/djt429

• View article